Cartesian Therapeutics to Participate in Upcoming Investor Conferences Feb 23, 2026 07:00AM
Cartesian Therapeutics' (RNAC) Descartes-08 Observed to Provide Deep and Sustained Benefits Through Month 12 After a Single Course of Therapy in Phase 2b Myasthenia Gravis Trial Apr 8, 2025 07:01AM
Cartesian Therapeutics’ Descartes-08 Observed to Provide Deep and Sustained Benefits Through Month 12 After a Single Course of Therapy in Phase 2b Myasthenia Gravis Trial Apr 8, 2025 07:00AM
Cartesian Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference Apr 1, 2025 07:00AM
Cartesian Therapeutics (RNAC) PT Lowered to $41 at Needham Aug 9, 2024 07:33AM


Jul 2, 2024 06:32AM Cartesian Therapeutics (RNAC) Enters $130M Private Placement
Jul 2, 2024 06:31AM Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing
Apr 4, 2024 07:30AM Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference